# RYTARY

NDC: 64896-663
Generic name: Carbidopa and Levodopa
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20150112

FDA application: NDA203312

## Active ingredients

- CARBIDOPA HYDRATE: 48.75 mg/1
- LEVODOPA: 195 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64896-663"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64896-663
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7